Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ALLOCYTE
- Development stage
- Unknown
- Lead developer
- Sanara MedTech
- Modality
- Cell Therapies, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Surgical Implantation
01
Overview
ALLOCYTE is an advanced cellular bone matrix allograft product composed of cryopreserved cancellous bone combined with cortical fibers, derived from donated human tissue. It is processed and distributed for use in surgical procedures requiring bone grafting, such as orthopedic or dental surgeries. The product is regulated as a human tissue allograft under USFDA 21 CFR Part 1271 and is intended to support new bone formation by providing a scaffold containing viable cells and natural bone matrix components. The mechanism of action relies on the osteoconductive and potentially osteoinductive properties of the graft, facilitating integration with host tissue to promote healing and regeneration at the implantation site[1][6].
- Brand names
- ALLOCYTE
- Other names
- ALLOCYTE Advanced Cellular Bone Matrix
Beyond the preview
Go deeper on ALLOCYTE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALLOCYTE.